HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2081044Generated: October 25, 2026
Ethylmorpholine → N-{[4-fluoro-3-(trifluoromethyl)phenyl]methyl}-3-methyl-2-oxo-4-imidazolidinecarboxamide
https://huagongshe.com/reaction/2081044
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Ethylmorpholine | HCID 7525 | — |
| Reactant | [4-Fluoro-3-(trifluoromethyl)phenyl]methanamine | HCID 522270 | — |
| Reactant | (S)-(-)-2-Oxo-1,5-imidazolidinedicarboxylic acid 1-benzyl ester | HCID 688196 | — |
| Reactant | 1,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-, monohydrochloride | HCID 2723939 | — |
| Reactant | 1-Hydroxybenzotriazole hydrate | HCID 2796029 | — |
| Reactant | 3-Methyl-2-oxoimidazolidine-4-carboxylic acid | HCID 55300151 | — |
| Reactant | 1,1-Dimethylethyl 3-methyl-2-oxo-4-imidazolidinecarboxylate | HCID 67103564 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | N-{[4-fluoro-3-(trifluoromethyl)phenyl]methyl}-3-methyl-2-oxo-4-imidazolidinecarboxamide | HCID 59252104 | 4.2% |
Reaction Steps
A mixture of 3-methyl-2-oxo-4-imidazolidinecarboxylic acid (86 mg, 0.6 mmol) (prepared as described in Example 28 from 1,1-dimethylethyl 3-methyl-2-oxo-4-imidazolidinecarboxylate, itself prepared as described in step (iii) of Example 13, starting originally from (4S)-2-oxo-3-{[(phenylmethyl)oxy]carbonyl}-4-imidazolidinecarboxylic acid), N-ethyl morpholine (0.380 ml, 3.00 mmol), 1-hydroxybenzotriazole hydrate (110 mg, 0.720 mmol) and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (138 mg, 0.720 mmol) in dichloromethane (9 ml) was stirred at room temperature for 10 minutes, under an argon atmosphere. {[4-Fluoro-3-(trifluoromethyl)phenyl]methyl}amine (127 mg, 0.660 mmol) was added and the reaction was stirred overnight under an argon atmosphere. The reaction mixture was diluted with dichloromethane (10 ml) and the solution was washed with saturated sodium hydrogen carbonate solution (10 ml), water (10 ml) and brine (10 ml). The organic solution was dried and the solvent was evaporated in vacuo. The residue was purified by mass-directed automated HPLC. Fractions containing product were collected and the solvent was evaporated in vacuo to give N-{[4-fluoro-3-(trifluoromethyl)phenyl]methyl}-3-methyl-2-oxo-4-imidazolidinecarboxamide (8 mg, 4% yield) as a white solid. LC/MS [M+H]+=320, retention time=1.87 minutes.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07932282B2 |
|---|
| Source dataset | uspto-grants-2011_04 |
|---|
| ORD ID | ord-bc58f31f31e14eaa9fb76fb6405eac77 |
|---|
| Source note | uspto-grants-2011_04 |
|---|